Matrix Gla Protein (MGP) Peptid
MGP
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
Produktnummer ABIN939467
Kurzübersicht für Matrix Gla Protein (MGP) Peptid (ABIN939467)
Target
MGP
(Matrix Gla Protein (MGP))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- INRRNANTFI SPQQRWRAKV QERIRERSKP VHELNREACD DYRLCERYAM
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MGP antibody,
Alternative Names: MGP control peptide, MGP antibody Blocking Peptide, Anti-MGP Blocking Peptide, Matrix Gla Protein Blocking Peptide, GIG36 Blocking Peptide, MGLAP Blocking Peptide, NTI Blocking Peptide -
Aufreinigung
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reaktivität: Human Wirt: Escherichia coli (E. coli) SDS
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Hintergrund
- MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
-
Molekulargewicht
- 12 kDa
Target
-
Sie sind hier:
